跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
VIMPAT lacosamide 200 mg/20 mL injection vial
Approved
STANDARD
VIMPAT lacosamide 200 mg/20 mL injection vial
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
9b46e55ece33372c
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
9b46e55ece33372c
Product Name
VIMPAT lacosamide 200 mg/20 mL injection vial
Artg Id
151815
Artg Name
VIMPAT lacosamide 200 mg/20 mL injection vial
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2009-07-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/60d97ca4a507e4a1b935e24266917c30.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1d42624d834adc3d644b4ad69345e439.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
9b46e55ece33372c
Type
Standard
Back to TGA Approvals
VIMPAT lacosamide 200 mg/20 mL injection vial - TGA Drug Approval Details